| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,316 |
11,070 |
$796K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,944 |
3,592 |
$357K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,769 |
1,751 |
$155K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,096 |
1,091 |
$100K |
| 96127 |
|
15,395 |
13,738 |
$50K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,822 |
1,795 |
$38K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
408 |
407 |
$35K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
349 |
346 |
$34K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
767 |
704 |
$32K |
| 99385 |
|
317 |
316 |
$29K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
594 |
547 |
$24K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
3,140 |
2,627 |
$16K |
| H0049 |
Alcohol and/or drug screening |
3,651 |
3,649 |
$16K |
| 96160 |
|
9,249 |
8,922 |
$15K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
952 |
925 |
$13K |
| 90686 |
|
1,080 |
1,079 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
10,604 |
10,081 |
$9K |
| 99051 |
|
2,039 |
1,929 |
$8K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,804 |
1,694 |
$8K |
| 99406 |
|
756 |
659 |
$6K |
| 99173 |
|
2,155 |
2,153 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
63 |
63 |
$5K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
10,495 |
9,186 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
689 |
671 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
139 |
134 |
$3K |
| 86769 |
|
83 |
82 |
$2K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
185 |
185 |
$2K |
| 90656 |
|
79 |
79 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
558 |
530 |
$1K |
| 90674 |
|
38 |
38 |
$1K |
| 90651 |
|
51 |
51 |
$910.74 |
| 95117 |
|
75 |
70 |
$687.11 |
| 87081 |
|
230 |
226 |
$573.47 |
| 99408 |
|
438 |
424 |
$565.16 |
| 81025 |
|
122 |
120 |
$348.79 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
21 |
18 |
$309.16 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
14 |
14 |
$240.63 |
| 90715 |
|
13 |
13 |
$111.50 |
| 86580 |
|
15 |
14 |
$101.72 |
| 81002 |
|
65 |
62 |
$90.04 |
| 82270 |
|
38 |
38 |
$83.06 |
| 3079F |
|
25 |
24 |
$64.24 |
| 3078F |
|
14 |
13 |
$20.00 |
| 4124F |
|
453 |
447 |
$14.88 |
| 90461 |
|
13 |
12 |
$13.55 |
| 3074F |
|
12 |
12 |
$4.24 |
| G9920 |
Screening performed and negative |
4,509 |
3,816 |
$0.00 |
| 99072 |
|
1,708 |
1,577 |
$0.00 |
| 3725F |
|
11,934 |
10,585 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
1,488 |
1,344 |
$0.00 |
| 90734 |
|
19 |
19 |
$0.00 |
| 1000F |
|
10,009 |
8,768 |
$0.00 |
| 1220F |
|
5,782 |
5,379 |
$0.00 |
| 4293F |
|
3,508 |
3,502 |
$0.00 |
| 90619 |
|
14 |
14 |
$0.00 |
| 94760 |
|
12 |
12 |
$0.00 |